Initiation of noninvasive ventilation in patients with amyotrophic lateral sclerosis.
amyotrophic lateral sclerosis
home mechanical ventilation
neuromuscular disease
noninvasive ventilation
respiratory failure
Journal
Muscle & nerve
ISSN: 1097-4598
Titre abrégé: Muscle Nerve
Pays: United States
ID NLM: 7803146
Informations de publication
Date de publication:
07 Sep 2024
07 Sep 2024
Historique:
revised:
25
08
2024
received:
17
04
2024
accepted:
27
08
2024
medline:
7
9
2024
pubmed:
7
9
2024
entrez:
7
9
2024
Statut:
aheadofprint
Résumé
Noninvasive ventilation (NIV) has been shown to improve survival and symptom burden in patients with amyotrophic lateral sclerosis (ALS). However, limited data exist regarding the clinical and physiological parameters at the time of NIV initiation. This study aimed to describe the clinical characteristics and respiratory physiological markers in a cohort of ALS patients with chronic respiratory failure. This is a single-center retrospective cohort study of patients with ALS assessed for NIV initiation between February 2012 and January 2021. NIV was initiated based on insurance eligibility criteria: daytime hypercapnia, defined by partial pressure of carbon dioxide (PaCO We identified 335 patients with ALS and chronic respiratory failure referred to an outpatient home ventilation clinic for NIV initiation. The mean age was 64 years ±11; 151 (45%) were female, 326 (97%) were white, and 100 (29%) had bulbar-onset ALS. At the time of NIV initiation, the mean FVC was 64% ± 19%, the mean MIP; 41 cmH We found that impairment in inspiratory force was the most common reason for NIV initiation and often preceded significant declines in FVC.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Muscular Dystrophy Association
ID : NIH NHLBI K23 HL-151879
Informations de copyright
© 2024 The Author(s). Muscle & Nerve published by Wiley Periodicals LLC.
Références
Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155(2):401‐408.
Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non‐invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5(2):140‐147.
Jacobs TL, Brown DL, Baek J, Migda EM, Funckes T, Gruis KL. Trial of early noninvasive ventilation for ALS: a pilot placebo‐controlled study. Neurology. 2016;87(18):1878‐1883.
Sarasate M, González N, Córdoba‐Izquierdo A, et al. Impact of early non‐invasive ventilation in amyotrophic lateral sclerosis: a multicenter randomized controlled trial. J Neuromuscul Dis. 2023;10(4):627‐637.
Ackrivo J, Hsu JY, Hansen‐Flaschen J, Elman L, Kawut SM. Noninvasive ventilation use is associated with better survival in amyotrophic lateral sclerosis. Ann Am Thorac Soc. 2021;18(3):486‐494.
Vitacca M, Montini A, Lunetta C, et al. Impact of an early respiratory care programme with non‐invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(3):556‐e33.
Lechtzin N, Scott Y, Busse AM, Clawson LL, Kimball R, Wiener CM. Early use of non‐invasive ventilation prolongs survival in subjects with ALS. Amyotroph Lateral Scler. 2007;8(3):185‐188.
Ackrivo J. Pulmonary care for ALS: progress, gaps, and paths forward. Muscle Nerve. 2023;67(5):341‐353.
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, Abrahams S, et al. EFNS guidelines on the clinical Management of Amyotrophic Lateral Sclerosis (MALS)—revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360‐375.
Khan A, Frazer‐Green L, Amin R, et al. Respiratory management of patients with neuromuscular weakness: an American College of Chest Physicians Clinical Practice Guideline and Expert Panel Report. Chest. 2023;164(2):394‐413.
Wolfe LF, Benditt JO, Aboussouan L, et al. Optimal NIV Medicare access promotion: patients with thoracic restrictive disorders: a technical expert panel report from the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of sleep medicine, and the American Thoracic Society. Chest. 2021;160(5):e399‐e408.
Miller RG, Jackson CE, Kasarskis EJ, et al. Quality standards Subcommittee of the American Academy of neurology. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence‐based review): report of the quality standards Subcommittee of the American Academy of neurology. Neurology. 2009;73(15):1218‐1226.
Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999;169(1–2):13‐21.
Mendoza M, Gelinas DF, Moore DH, Miller RG. A comparison of maximal inspiratory pressure and forced vital capacity as potential criteria for initiating non‐invasive ventilation in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8(2):106‐111.
Kelly CR, Parra‐Cantu C, Thapa P, et al. Comparative performance of different respiratory test parameters for detection of early respiratory insufficiency in patients with ALS. Neurology. 2022;99(7):e743‐e750.
Georges M, Golmard JL, Llontop C, et al. Initiation of non‐invasive ventilation in amyotrophic lateral sclerosis and clinical practice guidelines: single‐centre, retrospective, descriptive study in a national reference centre. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(1–2):46‐52.
Réginault T, Wibart P, Mathis S, le Masson G, Pillet O, Grassion L. Factors associated with survival after early at‐home NIV initiation in ALS patients. J Neurol. 2024;23:5590‐5597.
Réginault T, Bouteleux B, Wibart P, et al. At‐home noninvasive ventilation initiation with telemonitoring in amyotrophic lateral sclerosis patients: a retrospective study. ERJ Open Res. 2023;9(1):00438‐2022.
Vitacca M, Vianello A. Scientific group on respiratory intensive Care of the Italian Association of hospital pulmonologists. Respiratory outcomes of patients with amyotrophic lateral sclerosis: an Italian nationwide survey. Respir Care. 2013;58(9):1433‐1441.
Ritsma BR, Berger MJ, Charland DA, et al. NIPPV: prevalence, approach and barriers to use at Canadian ALS centres. Can J Neurol Sci. 2010;37(1):54‐60.
Musson LS, Baxter SK, Norman P, et al. Delivery of noninvasive ventilation to people living with motor neuron disease in the UK. ERJ Open Res. 2023;9(2):00388‐2022.
Giosa L, Busana M, Bonifazi M, et al. Mobilizing carbon dioxide stores. An experimental study. Am J Respir Crit Care Med. 2021;203(3):318‐327.
Jimenez JV, Ackrivo J, Hsu JY, et al. Lowering PCO2 with noninvasive ventilation is associated with improved survival in chronic Hypercapnic respiratory failure. Respir Care. 2023;68(12):1613‐1622.
Park KH, Kim RB, Yang J, et al. Reference range of respiratory muscle strength and its clinical application in amyotrophic lateral sclerosis: a single‐center study. J Clin Neurol. 2016;12(3):361‐367.